TY - JOUR
KW - Administration, Inhalation
KW - *Asthma/drug therapy
KW - *Covid-19
KW - Humans
KW - Nebulizers and Vaporizers
KW - Pandemics
KW - Prescriptions
KW - SARS-CoV-2
AU - C. Bloom
AU - E. Wong
AU - K. Hickman
AU - S. Elkin
AD - National Heart and Lung Institute, Imperial College London, Guy Scadding Building, Dovehouse Street, London, SW3 6LY, UK. Chloe.bloom06@imperial.ac.uk.
Imperial College Healthcare NHS Trust and Imperial College London, NHLI, London, UK.
West Yorkshire & Harrogate Health and Care Partnership, Low Moor Medical Practice, Bradford, West Yorkshire, UK.
AN - 34824265
BT - NPJ Prim Care Respir Med
C2 - PMC8617286
DO - 10.1038/s41533-021-00260-w
DP - NLM
ET - 2021/11/27
LA - eng
M1 - 1
N1 - 2055-1010
Bloom, C I
Orcid: 0000-0003-1285-7602
Wong, E
Hickman, K
Elkin, S
Journal Article
England
NPJ Prim Care Respir Med. 2021 Nov 25;31(1):45. doi: 10.1038/s41533-021-00260-w.
PY - 2021
SN - 2055-1010
EP - 45
T2 - NPJ Prim Care Respir Med
TI - Influence of the first wave of COVID-19 on asthma inhaler prescriptions
VL - 31
ER -